Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CZR | CAESARS ENTERTAINMENT INC | $5.63B | $11.30B | $3.58B | -$235.00M | -$1.09 | -1.25% | 36.72% | N/A | N/A | |||
| SPB | SPECTRUM BRANDS HOLDINGS INC | $1.66B | $2.97B | $329.30M | $119.30M | $4.10 | 2.56% | 4.04% | -91.36% | -17.99% | 2025-05-07 | ||
| OTLY | OATLY GROUP AB | $303.47M | $823.67M | -$78.11M | -$201.95M | -$6.80 | 5.15% | 32.19% | N/A | N/A | |||
| HUMA | HUMACYTE INC | $224.92M | $0.00 | -$132.18M | -$148.70M | -$1.26 | N/A | -100.00% | N/A | N/A | 2025-05-08 | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $352.60M | $0.00 | -$127.93M | -$129.47M | -$2.20 | N/A | N/A | N/A | N/A | 2025-05-06 | ||
| PASG | PASSAGE BIO INC | $20.26M | $0.00 | -$61.69M | -$64.77M | -$1.07 | N/A | N/A | N/A | N/A | 2025-05-12 | ||
| LENZ | LENZ THERAPEUTICS INC | $785.39M | $0.00 | -$49.71M | -$49.77M | -$2.34 | N/A | N/A | N/A | N/A | |||
| IAC | IAC INC | $2.91B | $3.81B | -$217.63M | -$539.90M | -$6.49 | -12.78% | 8.69% | N/A | N/A | 2025-05-05 | ||
| VERA | VERA THERAPEUTICS INC | $1.49B | $0.00 | -$142.35M | -$152.15M | -$2.75 | N/A | N/A | N/A | N/A | 2025-05-15 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.